How a Strong Dollar Affects Pharmaceutical Stocks
A strong dollar might have put a smile on the face of the U.S. consumer, but it generally means bad news for pharmaceutical stocks.
Investors Just Doubled Their Money on This Stock
Alexion is paying $8.4 billion to buy Synageva, a company without any sales, so in today's episode we're digging into this deal to see what it may mean to biotech investors.
Will Suitors Line Up to Buy These Biotech Stocks Next?
BioMarin Therapeutic Inc. and Amicus Therapeutics, Inc. are working on ultra-rare disease drugs that could attract an acquirer.
10 Most Profitable Companies in Healthcare
Like super-profitable companies? These healthcare stocks might be just what the doctor ordered.